Kaposi Sarcoma Treatment Market Size

Kaposi Sarcoma Treatment Market Size

Kaposi Sarcoma Treatment Market size was valued at USD 140.2 million in 2023 growing at a CAGR of 4.8% between 2024 and 2032, driven by factors such as the increase in the prevalence of Kaposi sarcoma, the rise in the number of patients diagnosed with KS, especially in regions with high HIV/AIDS prevalence, drives demand for effective treatments.

To get key market trends

  Download Free Sample

In addition, Kaposi sarcoma (KS) is more common in individuals with compromised immune systems, such as those with HIV/AIDS. For instance, as per the report published by American Cancer Society, the KS occurs at a rate of about 6 cases per million people each year. Furthermore, transplant recipients are another group that gets KS. About 1 in 200 transplant patients in the U.S. gets affected by KS. Moreover, continuous research and development leading to new and more effective treatments, including antiretroviral therapy (ART), chemotherapy, targeted therapy, and immunotherapy, enhance treatment outcomes and expand market growth.

Kaposi sarcoma is a type of cancer that forms in the lining of blood vessels and lymph vessels. The cancer forms growths of cells, called lesions, on the skin. The lesions often form on the face, arms, and legs. The lesions may look pink, red, purple, or brown.   The cause of Kaposi sarcoma is infection with the virus human herpes virus, also called HHV. In healthy people, this infection usually causes no symptoms because the immune system keeps it under control.